United Hospital Center (UHC) is proud to introduce a powerful new MRI solution for targeted biopsy of the prostate. Through our recent adoption of the UroNav fusion biopsy system, we can offer a truly new biopsy option for many patients with elevated and/or rising PSA levels.
“Other than skin cancer, prostate cancer has become the most common form of cancer in American men and the second-leading cause of cancer deaths in this population, said Oluyemi Akin-Olugbade, M.D., (Dr. Yemi), urologist at UHC Urology. “As one man in six will be diagnosed with prostate cancer during his lifetime, UHC Urology‘s introduction of MRI/ultrasound fusion biopsy could not have come at a more opportune time.”
UroNav fuses pre-biopsy MRI images of the prostate with ultrasound-guided biopsy images in real time, for excellent delineation of the prostate and suspicious lesions. After a patient has undergone a prostate MRI, radiologists utilize DynaCAD for Prostate to quickly visualize and evaluate suspicious lesions.
The UroNav fusion biopsy system uses this critical diagnostic information to provide the urologists with a targeted approach to prostate biopsy. The fusion of MRI and ultrasound images through UroNav gives urologists the ability to offer their patients an alternative to remaining in an uncertain state of diagnosis after a prostate exam.
“We are confident that this new technology will bring new hope to patients and provide our healthcare providers with the latest technology to identify and target suspicious prostate lesions,” said Dr. Yemi. “Targeted MRI/ultrasound biopsy is poised to become the new standard in prostate care, and UHC Urology is pleased to be the first urology practice in North Central West Virginia to offer this powerful solution to our patients.”
For more information about UHC Urology and MRI/ultrasound fusion, please call us at 681-342-3660 or visit us on the web at www.uhcwv.org.